{"version":"1.0","type":"link","title":"Optimizing anti-PI3Kδ and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple-negative breast cancer improves outcome by removing treatment-related adverse events.","author_name":"Lauder SN 외","author_url":"https://prs-insight.online/author/Lauder%20SN","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/86393","thumbnail_width":1200,"thumbnail_height":630}